Abstract:Objective The purpose of this study was to develop a high-throughput micro-plate radiobinding assay (RBA) of glutamic acid decarboxylase antibody (GAD-Ab) and to evaluate its clinical application. Methods 35labeled GAD65 antigen was incubated with sera for 24 h on a 96-well plate, and then transferred to the Millipore plate coated with protein A, which was washed with 4℃ PBS buffer, and then counted by a liquid scintillation counter. The GAD-Ab results were expressed by WHO standard unit (U/ml). A total of 224 healthy controls, 162 patients with type 1 diabetes mellitus(T1DM) and 210 patients with newly diagnosed type 2 diabetes (T2DM) were recruited. A total of 119 TI DM and healthy cases with gradually changing GAD-Ab levels were selected to compare the consistency of micro-plate RBA with conventional radioligand assay (RLA). Blood samples were obtained from the peripheral vein and finger tip in 32 healthy controls, 35 T1DM and 24 T2DM patients, and tested with micro-plate RBA and then compared with the conventional RLA to investigate the reliability of finger tip sampling. Linear correlation,student's t-test, variance analysis and receiver operating characteristic (ROC) curve were performed using SPSS 11.5. Results (1) The optimized conditions of micro-plate RBA included 2 μl serum incubated with3 ×104 counts/min 35S-GAD for 24 h under slow vibration, antigen-antibody compounds washed 10 times by 4℃ PBS buffer, and radioactivity counted with Optiphase Supermix scintillation liquid. (2)The intra-batch CV of the micro-plate RBA was 3.8%- 10.2%, and the inter-batch CV was 5.6%- 11.9%. The linearity analysis showed a good correlation when the GAD-Ab in serum samples ranged from 40.3 to 664 U/ml and the detection limit of measurement was 3.6 U/ml. The results from Diabetes Autoantibody Standardization Program (DASP) 2005 showed that the sensitivity and specificity for GAD-Ab were 78% (39 positive among 50 new-onset T1DM) and 98% (2 positive among 100 healthy controls). The results of GAD-Ab obtained with micro-plate RBA and RLA were closely correlated (r=0.915,P<0.001) with a high concordance level of 97.5% and a Kappa value of 0.95. (3)TI DM and T2DM patients showed higher positive rates for GAD-Ab than the healthy controls(46.9% and 5.2% vs 0.89% ,X2=123.5 and 10. 1 ,P <0.001 and <0.01, respectively). (4)The consistency of GAD-Ab measurement with RBA using finger tip blood and RLA measurement using venous blood was 96.7% (r =0.946,P <0.001, Kappa value: 0.905). Conclusions The micro-plate RBA of GAD-Ab has high sensitivity, specificity and reproducibility, and can be measured with finger tip blood sampling. It might be a better alternative for clinical practice.

Cloning,expression and Diagnostic Application for Type 1 Diabetes Mellitus of Human Glutamic Acid Decarboxylase 65 Gene

Expression and Activity of Recombinant Human Glutamate Decarboxylase 65

Cloning,Expression and Diagnostic Evaluation of the Fragments of Human Protein Tyrosine Phosphatase-Like Protein IA-2

Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide Gad(500-585)

Preparation of Recombinant Islet Cell Autoantigen 69 kD Fusion Protein

Construction and Identification of 2 Secreted Human GAD65 Fragment DNA Vaccines

[Detection of GAD65 Reactive T Cells in Some Chinese Subjects Initially Diagnosed As with Idiopathic Type 1 Diabetes].

Micro-plate radiobinding assay of autoantibody to glutamic acid decarboxylase

SERS-based Detection of Early Type 1 Diabetes Mellitus Biomarkers: Glutamate Decarboxylase Antibody and Insulin Autoantibody

The diabetic antigen glutamic acid decarboxylase (GAD 65) in the human peripheral blood

Construction and Identification of Eukaryotic Expression Vector Containing GAD65 Fragment and IL-10 Gene

Detection of Glutamate Decarboxylase Antibodies and Simultaneous Multi-Molecular Translocation Exploration by Glass Nanopores

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.

Diagnostic Values of Combining Detection of GADA、ICA and IAA in Type 1 Diabetes Mellitus

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

Expression and Identification of Type 1 Diabetes Associated Autoantigen IA-2

Establishment of a New Method to Evaluate Autoantibodies of Glutamic Acid Decarboxylase

Clinical Evaluation of Autoantibodies to Glutamic Acid Decarboxylase and Islet Cell in the Diagnosis of Iddm

Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects

[Expression of Zinc Transporter 8 in Saccharomyces Cerevisiae and Its Antigenicity Analysis].

Construction and Expression of Co-expression DNA Vaccines Containing GAD65 Fragment and Insulin B Chain Gene